Accenture (ACN) has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes. The platform, which went live at Bayer earlier this year, brings internal and external clinical data together with Oracle cloud-based technologies into a single data management and warehousing platform, creating actionable insights to accelerate drug development and improve patient outcomes. The Accenture INTIENT Clinical platform is part of Accenture INTIENT™ and builds upon Accenture’s market-proven platforms for research, clinical development, pharmacovigilance and patient services.
blaineonline.finance.blog 